Insider buying
~$4.2K1,200 sh @ $3.53
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $4.2K out of pocket for Aquestive Therapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 12, 2026
Routine share withholding; mechanical by default.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Insider buying
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $4.2K out of pocket for Aquestive Therapeutics shares.
Matthew W Davis (Officer) plans to sell ~$26K of Aquestive Therapeutics
Planned, from payInsider buying
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $95K out of pocket for Aquestive Therapeutics shares. Shares held went up 2235% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.